Serial #76491276
DEAD

Serial Number

76491276

Owner

KYOWA HAKKO KOGYO CO., LTD.

Attorney

KAUSHAL R. ODEDRA, ESQ.

First Use Date

Jul 1, 1981

Filing Date

Feb 21, 2003

Add to watchlist:

No watchlists yet
View on USPTO

Serial #76491276 Trademark

Serial Number: 76491276 • Registration: 3068626

Serial #76491276 is a trademark filed by KYOWA HAKKO KOGYO CO., LTD. on February 21, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

KYOWA HAKKO KOGYO CO., LTD. (51 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

February 21, 2003

Registration Date

March 14, 2006

First Use Anywhere

July 1, 1981

First Use in Commerce

July 1, 1981

Published for Opposition

August 3, 2004

Cancellation Date

October 19, 2012

Goods & Services

Custom manufacturing of antibody, fragment of antibody or derivatives of antibody; custom manufacturing of cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of host cells

Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for clinical or medical use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for clinical or medical use; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for clinical or medical use; host cells for clinical or medical use; pharmaceuticals, namely, central nervous system depressants; preparations for ophthalmic use, anti-histaminics; cardiotonics; arrhythmia treating agents; diuretics; hypotensors; prophylactic for the treatment of asthma; antitussives and expectorants; stomachics and digestives; antacids; hormones, namely, pituitary hormones for the treatment of infertility; thyroid hormones for the treatment of hyperthyroidism; anabolic hormones for the treatment of a plastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics; analgesics; anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents for treating vitamin deficiencies; anti-coagulants; enzyme preparations for control of malabsorption and diarrhea; anti-cancer preparations; anti-sarcoma preparations; antibiotics and their preparations for the treatment of infectious diseases; antituberculotic agents; influenza vaccines; diphtheria vaccines; tetanus vaccines; gas gangrene vaccines, Japanese encephalitis vaccines; in vitro tetrodotoxines for medical use; antiprotozoals for the treatment of trichomoniasis and dermatophytosis; anthelmintics for the treatment of thread worm and toxoplasmaosis; naturally occurring drugs for treating peptic ulcers; charred drugs for treating peptic ulcers; moxa for treating peptic ulcers; veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use; antiseptics; drugs for arteriosclerosis; oncostatic drugs for the treatment for cancer; multi enzyme digestants for in vivo use; anti fungal antibiotics for treating trichomoniasis and dermatophytosis; antiparkinsonism drugs; minor tranquilizers; and anti anxiety agents; medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; vitamins; anti-bacterial preparations; mucolytic preparations; medicinal preparations for the treatment of peptic ulcers; anti-inflammatory preparations; analgesic preparations; cephalosporin; cocarboxylase preparations; gluthathione preparations; preparations for improving the metabolism and the peripheral circulation; plasma substitutes and extra corporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media; pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for scientific laboratory or medical research; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for scientific, laboratory or medical research; host cells for scientific, laboratory or medical research

Contract development for antibody, fragment of antibody or derivatives of antibody; contract development for cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for host cells

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 19, 2012 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2010 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 14, 2006 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 31, 2006 REGV
ASSIGNED TO LIE
Jan 20, 2006 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 19, 2006 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 7, 2005 SUPC
USE AMENDMENT FILED
Nov 10, 2005 IUAF
PAPER RECEIVED
Nov 10, 2005 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 10, 2005 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 2, 2005 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 2, 2004 ETOF
PUBLISHED FOR OPPOSITION
Aug 3, 2004 PUBO
NOTICE OF PUBLICATION
Jul 14, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2004 CNSA
EXAMINERS AMENDMENT MAILED
May 3, 2004 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2004 CRFA
PAPER RECEIVED
Feb 10, 2004 MAIL
NON-FINAL ACTION MAILED
Aug 12, 2003 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2003 DOCK
PAPER RECEIVED
Mar 20, 2003 MAIL